Cargando…
Anti–SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023
IMPORTANCE: Several pharmacotherapies have been authorized to treat nonhospitalized persons with symptomatic COVID-19. Longitudinal information on the use of these therapies is needed. OBJECTIVE: To analyze trends and factors associated with prescription of outpatient COVID-19 pharmacotherapies with...
Autores principales: | Yan, Lei, Streja, Elani, Li, Yuli, Rajeevan, Nallakkandi, Rowneki, Mazhgan, Berry, Kristin, Hynes, Denise M., Cunningham, Francesca, Huang, Grant D., Aslan, Mihaela, Ioannou, George N., Bajema, Kristina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472184/ https://www.ncbi.nlm.nih.gov/pubmed/37651140 http://dx.doi.org/10.1001/jamanetworkopen.2023.31249 |
Ejemplares similares
-
Early Adoption of Anti–SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022
por: Bajema, Kristina L., et al.
Publicado: (2022) -
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
por: Bajema, Kristina L., et al.
Publicado: (2022) -
Cholera Outbreak — Haiti, September 2022–January 2023
por: Vega Ocasio, Denisse, et al.
Publicado: (2023) -
Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022
por: Bajema, Kristina L., et al.
Publicado: (2023) -
In the Literature: January 2023
por: Martín-Arana, J., et al.
Publicado: (2023)